Denosumab Boosts Bone Strength in Glucocorticoid Users

Compared with risedronate, denosumab promoted bone strength in patients initiating glucocorticoids and those on long-term therapy.
Medscape Medical News

source https://www.medscape.com/viewarticle/971978?src=rss

Comments

Popular posts from this blog

New AAFP practice guideline sets blood pressure targets for adults with hypertension